Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lissoni

Showing results (271-280 of 287) with videos related to

Pageof 29
Sort By:
Anticancer Research|July 18, 2008
Free-from-progression period and overall short preoperative immunotherapy with IL-2 increases the survival of pancreatic cancer patients treated with macroscopically radical surgeryR Caprotti, F Brivio, L Fumagalli, et al.
Oncology|June 16, 2001
Progress report on the palliative therapy of 100 patients with neoplastic effusions by intracavitary low-dose interleukin-2P Lissoni, M Mandalà, G Curigliano, et al.
Tumori|April 25, 2000
Endocrinological study of the dopaminergic regulation of prolactin release in metastatic breast cancerM Mandalà, P Lissoni, A Ardizzoia, et al.
European Urology|January 1, 1997
Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue aloneP Lissoni, M Cazzaniga, G Tancini, et al.
In Vivo (Athens, Greece)|June 21, 2002
A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alphaP Lissoni, M Vaghi, A Ardizzoia, et al.
In Vivo (Athens, Greece)|October 16, 2008
T-helper/T-regulator lymphocyte ratio as a new immunobiological index to quantify the anticancer immune status in cancer patientsF Brivio, L Fumagalli, D Parolini, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1996
Clinical significance of erythrosedimentation rate in cancer in relation to cytokine production: correlation with high IL-6 and low IL-2 blood concentrationsP Lissoni, F Brivio, S Pittalis, et al.
Neuro Endocrinology Letters|July 13, 2001
A review on cancer--psychospiritual status interactionsP Lissoni, P Cangemi, D Pirato, et al.
In Vivo (Athens, Greece)|February 5, 2004
A psychoneuroendocrine study of brain dopaminergic sensitivity in locally limited or metastatic cancer patientsP Lissoni, G Messina, M Vaghi, et al.
Minerva Medica|February 27, 2008
A progress study of 100 cancer patients treated by acupressure for chemotherapy-induced vomiting after failure with the pharmacological approachG Gardani, R Cerrone, C Biella, et al.
Pageof 29

Showing results (271-280 of 287) with videos related to

Sort By:
Pageof 29
Anticancer Research|July 18, 2008
Free-from-progression period and overall short preoperative immunotherapy with IL-2 increases the survival of pancreatic cancer patients treated with macroscopically radical surgeryR Caprotti, F Brivio, L Fumagalli, et al.
Oncology|June 16, 2001
Progress report on the palliative therapy of 100 patients with neoplastic effusions by intracavitary low-dose interleukin-2P Lissoni, M Mandalà, G Curigliano, et al.
Tumori|April 25, 2000
Endocrinological study of the dopaminergic regulation of prolactin release in metastatic breast cancerM Mandalà, P Lissoni, A Ardizzoia, et al.
European Urology|January 1, 1997
Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue aloneP Lissoni, M Cazzaniga, G Tancini, et al.
In Vivo (Athens, Greece)|June 21, 2002
A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alphaP Lissoni, M Vaghi, A Ardizzoia, et al.
In Vivo (Athens, Greece)|October 16, 2008
T-helper/T-regulator lymphocyte ratio as a new immunobiological index to quantify the anticancer immune status in cancer patientsF Brivio, L Fumagalli, D Parolini, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1996
Clinical significance of erythrosedimentation rate in cancer in relation to cytokine production: correlation with high IL-6 and low IL-2 blood concentrationsP Lissoni, F Brivio, S Pittalis, et al.
Neuro Endocrinology Letters|July 13, 2001
A review on cancer--psychospiritual status interactionsP Lissoni, P Cangemi, D Pirato, et al.
In Vivo (Athens, Greece)|February 5, 2004
A psychoneuroendocrine study of brain dopaminergic sensitivity in locally limited or metastatic cancer patientsP Lissoni, G Messina, M Vaghi, et al.
Minerva Medica|February 27, 2008
A progress study of 100 cancer patients treated by acupressure for chemotherapy-induced vomiting after failure with the pharmacological approachG Gardani, R Cerrone, C Biella, et al.
Pageof 29